Incyte Corporation, a Delaware-based biopharmaceutical company, focuses on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology.

- New facility to serve as European base for Incyte’s drug development operations

- Location provides efficient access to key clinical trial experts and institutions
http://investor.incyte.com/phoenix.zhtml?c=69764&p=irol-newsArticle&ID=2034738
Find an actor

Medtec Japan Tokyo 201818.04.2018

The exhibition will take place from 18 to 20 April at the Big Sight Exhibition Centre in Tokyo, Japan. BioAlps will...

Gene Predictis - Tests génétiques pour prévenir les risques liés aux effets adverse

Des tests pour réduire les risques d'effets nocifs liés aux médicaments et à la nutrition. Un article de l'AGEFI
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn